<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Washington_Gram_Positive"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Washington/Gram_Positive">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Washington/Gram_Positive&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Washington/Gram_Positive&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Washington/Gram_Positive&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Washington/Gram_Positive" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Washington/Gram Positive</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2010.igem.org</H3><DIV id="uw_leftBar"><DIV id="uw_ss"><UL id="uw_navBar"><LI><A href="/Team:Washington" title="Team:Washington"><SPAN style="color:#F0F7C1">Home</SPAN></A></LI><LI><A href="/Team:Washington/Gram_Negative" title="Team:Washington/Gram Negative"><SPAN style="color:#F0F7C1">Gram(-) Therapeutic</SPAN></A></LI><LI><A href="/Team:Washington/Gram_Negative/Design" title="Team:Washington/Gram Negative/Design"><SPAN style="color:#F0F7C1">Design</SPAN></A></LI><LI><A href="/Team:Washington/Gram_Negative/Build" title="Team:Washington/Gram Negative/Build"><SPAN style="color:#F0F7C1">Build</SPAN></A></LI><LI><A href="/Team:Washington/Gram_Negative/Test" title="Team:Washington/Gram Negative/Test"><SPAN style="color:#F0F7C1">Test Results</SPAN></A></LI></UL><LI><STRONG class="selflink"><SPAN style="color:#F0F7C1">Gram(+) Therapeutic</SPAN></STRONG></LI><LI><A href="/Team:Washington/Gram_Positive/Design" title="Team:Washington/Gram Positive/Design"><SPAN style="color:#F0F7C1">Design</SPAN></A></LI><LI><A href="/Team:Washington/Gram_Positive/Build" title="Team:Washington/Gram Positive/Build"><SPAN style="color:#F0F7C1">Build</SPAN></A></LI><LI><A href="/Team:Washington/Gram_Positive/Test" title="Team:Washington/Gram Positive/Test"><SPAN style="color:#F0F7C1">Test Results</SPAN></A></LI><LI><A href="/Team:Washington/Tools_Created" title="Team:Washington/Tools Created"><SPAN style="color:#F0F7C1">Tools Created</SPAN></A></LI><LI><A href="/Team:Washington/Tools_Created/New_Vectors" title="Team:Washington/Tools Created/New Vectors"><SPAN style="color:#F0F7C1">New Vectors</SPAN></A></LI><LI><A href="/Team:Washington/Tools_Created/New_Software" title="Team:Washington/Tools Created/New Software"><SPAN style="color:#F0F7C1">New Software</SPAN></A></LI><LI><A href="/Team:Washington/Tools_Used" title="Team:Washington/Tools Used"><SPAN style="color:#F0F7C1">Tools Used</SPAN></A></LI><LI><A href="/Team:Washington/Tools_Used/Software" title="Team:Washington/Tools Used/Software"><SPAN style="color:#F0F7C1">Software</SPAN></A></LI><LI><A href="/Team:Washington/Tools_Used/Next-Gen_Cloning" title="Team:Washington/Tools Used/Next-Gen Cloning"><SPAN style="color:#F0F7C1">Next-Gen Cloning</SPAN></A></LI><LI><A href="/Team:Washington/Protocols" title="Team:Washington/Protocols"><SPAN style="color:#F0F7C1">Protocols</SPAN></A></LI><LI><A href="/Team:Washington/Safety" title="Team:Washington/Safety"><SPAN style="color:#F0F7C1">Safety</SPAN></A></LI><LI><A href="/Team:Washington/Team" title="Team:Washington/Team"><SPAN style="color:#F0F7C1">Meet the Team</SPAN></A></LI><LI><A href="/Team:Washington/Accomplishments" title="Team:Washington/Accomplishments"><SPAN style="color:#F0F7C1">Accomplishments</SPAN></A></LI><LI><A href="/Team:Washington/Parts" title="Team:Washington/Parts"><SPAN style="color:#F0F7C1">Parts Submitted</SPAN></A></LI><LI><A href="/Team:Washington/Notebook" title="Team:Washington/Notebook"><SPAN style="color:#F0F7C1">Notebook</SPAN></A></LI><LI><A href="/Team:Washington/Bibliography" title="Team:Washington/Bibliography"><SPAN style="color:#F0F7C1">References</SPAN></A></LI></DIV></DIV><DIV id="uw_content"><H1><SPAN class="mw-headline" id="Development_of_a_Novel_Anthrax_Therapeutic"><BIG><B>Development of a Novel Anthrax Therapeutic</B></BIG></SPAN></H1><H2><SPAN class="mw-headline" id="Anthrax_still_poses_a_major_threat"><B>Anthrax still poses a major threat</B></SPAN></H2><DIV class="thumb tright"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption"><I>Bacillus anthracis</I></DIV></DIV></DIV><P>Anthrax is a lethal disease caused by the bacterium <I>Bacillus anthracis</I>, which can spread by ingestion, inhalation, or cutaneous lesion contact of spores. This disease is not contagious, cannot be transferred from an infected organism, though bacterial spores can be transported in a multitude of ways and will infect potential victims. <A href="#References"> [1]</A></P><P>
One of the primary reasons that Bacillus anthracis is such a deadly pathogen is its ability to evade the human immune system.  The bacterium cloaks itself in an outer coat of poly-γ-D-glutamate (PDG) that confers antiphagocytic properties on the organism, and is essential for virulence <A href="#References"> [2]</A></P><P>
The protective PDG coat is synthesized on the surface of <I>B. anthracis</I> by a series of enzymes.  A key step of the synthesis is done by the enzyme CapD, which takes portions of a long strand of PDG, which is continuously secreted from the cell, and transfers it to the peptidoglycan layer through a transpeptidation reaction. It is important to note, however, that CapD has also been shown to have the capacity to catalyze hydrolysis of PDG during this process, but at a rate much slower than the competing transpeptidation reaction. <A href="#References"> [3]</A></P><P>
This small amount of hydrolase activity was co-opted in a therapeutic capacity in a guinea pig model <A href="#References"> [4]</A>. When wild type CapD was overexpressed, the small amount of hydrolase activity inherent in the many copies of the enzyme that were produced was sufficient to compromise the protective coating of the bacterium. The immune system was then able to clear the infection much more effectively.  We therefore hoped to engineer a mutant CapD protein for which the propensity to carry out a protective transpeptidation reaction was reduced, and the propensity to hydrolyze the protective coat was increased.  If a mutant CapD with hydrolytic, rather than transpeptidation activity (which we term CapH) could be engineered, a single, highly concentrated dose of the protein in an infected individual could prove a potent therapeutic. Alternatively, simply ablating the protective transpeptidase activity without compromising the pre-existing hydrolase activity would likely dramatically increase the potency of this protein as a potential therapeutic.
</P><H2><SPAN class="mw-headline" id="Capsule_Depolymerase_.28CapD.29:_Capsule_Creator_and_Destroyer">Capsule Depolymerase (CapD):  Capsule Creator and Destroyer </SPAN></H2><P>Anthrax creates a poly-γ-D-glutamate (PDG) capsule which prevents the immune system from recognizing it as a pathogen and performing phagocytosis to eliminate the threat. Researchs have shown that adding the enzyme capsule depolymerase to anthrax naturally, anthrax excretes a long strand of PDG and uses its CapD to cleave and anchor the PDG to its peptidoglycan, the outer coat of the cell membrane, as a protective capsule. CapD can also cut and release its capsule into small pieces that can interfere with the immune responses.
</P><H2><SPAN class="mw-headline" id="Potential_Weapon_against_Anthrax">Potential Weapon against Anthrax</SPAN></H2><P>Research based on a guinea pig model shows overexpression of CapD will destroy the capsule, removing anthrax's immunity to phagocytosis.
CapD is naturally a transpeptidase, favoring reactions with amino acids to cleave PDG. However, CapD would be invaluable as a hydrolase, reacting efficiently with water, because of high water content in the human bloodstream. If a mutant CapD could be engineered as an extremely efficient hydrolase, it is theorized that a single dose of concentrated CapD into the blood stream would easily decimate anthrax populations, nullifying its lethal properties. <A href="#References"> [4]</A></P><H2><SPAN class="mw-headline" id="References">References</SPAN></H2><P>1. Lucey DR, Anthrax. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 317.
</P><P>2.  Angelo Scorpio, Donald J. Chabot, William A. Day, David K. O'Brien, Nicholas J. Vietri, Yoshifumi Itoh, Mansour Mohamadzadeh, and Arthur M. Friedlander.  Poly-γ-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of Encapsulated Bacillus anthracis Antimicrobial Agents and Chemotherapy, January 2007, p. 215-222,Vol. 51, No. 1.  PMCID: PMC1797643
</P><P>3.  Candela T, Fouet A.  Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan.  Mol Microbiol. 2005 Aug;57(3):717-26.  PMID: 16045616
</P><P>4. Angelo Scorpio, Donald J Chabot, William A Day, Timothy A Hoover, and Arthur M Friedlander.  Capsule depolymerase overexpression reduces Bacillus anthracis virulence Microbiology 2010 : mic.0.035857-0v1-mic.0.035857-0. PMID: 20110296 
</P><DIV style="text-align:center"><P><B>←<A href="/Team:Washington/Gram_Negative/Test" title="Team:Washington/Gram Negative/Test">Testing the Gram(-) Therapeutic</A></B>   <B><A href="/Team:Washington/Gram_Positive/Design" title="Team:Washington/Gram Positive/Design">Designing the Gram(+) Therapeutic</A>→</B></P></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2010.igem.org/Team:Washington/Gram_Positive">http://2010.igem.org/Team:Washington/Gram_Positive</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Washington/Gram_Positive" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Washington/Gram_Positive" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Washington/Gram_Positive&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Washington/Gram_Positive&amp;oldid=196144" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2010.igem.org:Privacy_policy" title="2010.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2010.igem.org:General_disclaimer" title="2010.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>